NOVT Stock Analysis: Buy, Sell, or Hold?
NOVT - Novanta Inc. Common Stock
$113.09
-0.06 (-0.05%)
▼
5d:
-3.63%
30d:
-15.87%
90d:
-7.85%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When NOVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NOVT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NOVT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$156.85
Based on 9.1% avg growth
INTRINSIC VALUE TODAY
$97.39
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NOVT is currently trading at $113.09, which is considered oversold relative to its 30-day fair value range of $116.80 to $137.87. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.8) compared to its historical average (34.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.6% over the next few years. This pessimistic expectation contrasts with the company's recent 0.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, NOVT is in a uptrend. The price is currently testing key support at $111.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NOVT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $160.00 (+41.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NOVT is in a uptrend. The price is currently testing key support at $111.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NOVT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $160.00 (+41.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$116.80 -
$137.87
Company Quality Score
53/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.4% below Wall St target ($160.00)
Fair Price Analysis
30-Day Fair Range
$116.80 -
$137.87
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$7.85
(6.9%)
Support & Resistance Levels
Support Level
$111.93
Resistance Level
$123.48
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.80
Wall Street Target
$160.00
(+41.4%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
0.6%
Profit Margin
5.5%
Valuation Discount vs History
-6.6% cheaper
PE vs Historical
27.8 vs 34.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.6%
(market-implied from PE analysis)
1-Year Target
$105.68
(-7%)
2-Year Target
$98.71
(-13%)
3-Year Target
$92.19
(-19%)
3-Yr Target (if PE normalizes)
(PE: 28→34)
$113.08
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.8, Growth: 14.2%)
$168.61
(+49%)
Base:
(SPY PE: 22.4, Growth: 14.2%)
$135.85
(+20%)
Bear:
(PE: 19.0, Growth: 14.2%)
$115.47
(+2%)
📈
Valuation based on Current Earnings
Forward PE: 8.39 | Forward EPS (Implied): $13.99
Bull Case
$141.70
(+21%)
Analyst growth 15.0%, PE expands to 8.8
Base Case
$117.35
(0%)
Market implied 0.0%, PE stable at 8.4
Bear Case
$89.77
(-24%)
Severe decline -15.0%, PE contracts to 7.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.8 to 34.1
Stabilization Target:
$138.79
(+22.7%)
PE Expansion Potential:
+22.7%
Share & Embed Analysis
Last updated: March 30, 2026 4:38 PM ET
Data refreshes hourly during market hours. Next update: 5:38 PM
Data refreshes hourly during market hours. Next update: 5:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NOVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Buckley
SELL
9957 shares
2026-03-16
Robert Buckley
SELL
1423 shares
2026-02-20
Matthijs Glastra
SELL
7500 shares
2026-02-10
Top Rated Scientific & Technical Instruments Stocks
Top-rated stocks in Scientific & Technical Instruments by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
COHR
Coherent Inc |
STRONG BUY
19 analysts |
$284 | 39 SELL |
|
CGNX
Cognex Corporation |
BUY
20 analysts |
$66 | 57 HOLD |
|
FTV
Fortive Corp |
BUY
20 analysts |
$63 | 56 HOLD |
|
TRMB
Trimble Inc |
STRONG BUY
12 analysts |
$91 | 55 HOLD |
|
KEYS
Keysight Technologies Inc |
STRONG BUY
13 analysts |
$299 | 56 HOLD |
